Marshall Wace’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,343
Closed -$1.31M 3105
2026
Q1
$1.31M Buy
+12,343
New +$1.4M ﹤0.01% 2004
2025
Q4
Sell
-50,609
Closed -$4.74M 2904
2025
Q3
$4.74M Buy
50,609
+28,503
+129% +$2.65M ﹤0.01% 1203
2025
Q2
$1.92M Buy
+22,106
New +$1.85M ﹤0.01% 1583
2025
Q1
Sell
-7,779
Closed -$753K 2578
2024
Q4
$753K Sell
7,779
-103
-1% -$10.4K ﹤0.01% 1868
2024
Q3
$747K Buy
+7,882
New +$688K ﹤0.01% 1769
2020
Q2
Sell
-6,473
Closed -$257K 1487
2020
Q1
$257K Sell
6,473
-29,310
-82% -$1.24M ﹤0.01% 1128
2019
Q4
$1.59M Sell
35,783
-147,419
-80% -$5.67M 0.01% 869
2019
Q3
$6.27M Sell
183,202
-134,618
-42% -$4.66M 0.05% 434
2019
Q2
$12M Sell
317,820
-361,431
-53% -$12.4M 0.1% 238
2019
Q1
$20.8M Buy
+679,251
New +$20.7M 0.2% 116

Other funds holding ACA

Marshall Wace's ACA Position: Q2 2026 in Review

Marshall Wace sold out of Arcosa (ACA) in Q2 2026, closing a stake of 12,343 shares — an estimated $1.31M sold.

Marshall Wace first reported a position in ACA in Q1 2019 and held it in 10 quarters. The position peaked at $20.8M in Q1 2019. 428 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • Marshall Wace reported no remaining Arcosa position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 12,343 Arcosa shares in Q2 2026, an estimated $1.31M.
  • Marshall Wace first reported a position in Arcosa in Q1 2019 and held it in 10 quarters.
  • Marshall Wace's Arcosa position peaked at $20.8M in Q1 2019.
  • 428 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.